76
Participants
Start Date
October 9, 2025
Primary Completion Date
June 6, 2026
Study Completion Date
October 10, 2026
ZT003
ZT003 is administered as a single subcutaneous injection at different dose levels.
ZT003
ZT003 administered as multiple subcutaneous injections at different dose levels.
Placebo
Matching placebo administered subcutaneously.
Nucleus Network Brisbane, Brisbane
Lead Sponsor
Beijing QL Biopharmaceutical Co.,Ltd
INDUSTRY